Neuropeptide S Ameliorates Cognitive Impairment of APP/PS1 Transgenic Mice by Promoting Synaptic Plasticity and Reducing Aβ Deposition

Alzheimer’s disease (AD) is a devastating disease in the elderly with no known effective treatment. It is characterized by progressive deterioration of memory and cognition. Many new potential targets are being investigated to develop effective therapeutic strategies for AD. Neuropeptide S (NPS) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Peng, Qian, Xiaohang, Nie, Yunjuan, Sun, Na, Wang, Zhongxuan, Wu, Jiajun, Wei, Chen, Ma, Ruikun, Wang, Zhe, Chai, Gaoshang, Li, Yuqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603143/
https://www.ncbi.nlm.nih.gov/pubmed/31293402
http://dx.doi.org/10.3389/fnbeh.2019.00138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603143/
https://www.ncbi.nlm.nih.gov/pubmed/31293402
http://dx.doi.org/10.3389/fnbeh.2019.00138

Ejemplares similares